These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18182810)

  • 1. Minocycline-induced DRESS: evidence for accumulation of the culprit drug.
    Maubec E; Wolkenstein P; Loriot MA; Wechsler J; Mulot C; Beaune P; Revuz J; Roujeau JC
    Dermatology; 2008; 216(3):200-4. PubMed ID: 18182810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis.
    Shaughnessy KK; Bouchard SM; Mohr MR; Herre JM; Salkey KS
    J Am Acad Dermatol; 2010 Feb; 62(2):315-8. PubMed ID: 19665822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe drug rash with eosinophilia and systemic symptoms after treatment with minocycline].
    Favrolt N; Bonniaud P; Collet E; Fayard M; Rabec C; Camus C; Bour JB; Camus P
    Rev Mal Respir; 2007 Sep; 24(7):892-5. PubMed ID: 17925673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.
    Vinson AE; Dufort EM; Willis MD; Eberson CP; Harwell JI
    Pediatr Crit Care Med; 2010 Jul; 11(4):e38-43. PubMed ID: 20407399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe episode of high fever with rash, lymphadenopathy, neutropenia, and eosinophilia after minocycline therapy for acne.
    Kaufmann D; Pichler W; Beer JH
    Arch Intern Med; 1994 Sep; 154(17):1983-4. PubMed ID: 8074603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemoid reaction in minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A brief report.
    Shea M; Weese K; Dhossche J
    Pediatr Dermatol; 2024; 41(1):141-142. PubMed ID: 37496096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fever, eosinophilia, and death: a case of minocycline hypersensitivity.
    Wu PA; Anadkat MJ
    Cutis; 2014 Feb; 93(2):107-10. PubMed ID: 24605348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug hypersensitivity syndrome caused by minocycline.
    Tsuruta D; Someda Y; Sowa J; Kobayashi H; Ishii M
    J Cutan Med Surg; 2006; 10(3):131-5. PubMed ID: 17241589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects of minocycline in the treatment of acne vulgaris].
    Hoefnagel JJ; van Leeuwen RL; Mattie H; Bastiaens MT
    Ned Tijdschr Geneeskd; 1997 Jul; 141(29):1424-7. PubMed ID: 9542866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit-risk assessment of acne therapies.
    Bénéton N; Bocquet H; Cosnes A; Revuz J; Roujeau JC
    Lancet; 1997 Apr; 349(9060):1252. PubMed ID: 9130968
    [No Abstract]   [Full Text] [Related]  

  • 11. [Systemic reaction induced my minocycline treatment: a report of four patients and a review of the literature].
    Piette AM; Ramanoelina J; Gepner P; Larroche C; Blétry O
    Rev Med Interne; 1999 Oct; 20(10):869-74. PubMed ID: 10573723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline.
    MacNeil M; Haase DA; Tremaine R; Marrie TJ
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 2):347-50. PubMed ID: 9039216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline in acne vulgaris: benefits and risks.
    Ochsendorf F
    Am J Clin Dermatol; 2010; 11(5):327-41. PubMed ID: 20642295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathology of drug rash with eosinophilia and systemic symptoms syndrome: a morphological and phenotypical study.
    Ortonne N; Valeyrie-Allanore L; Bastuji-Garin S; Wechsler J; de Feraudy S; Duong TA; Delfau-Larue MH; Chosidow O; Wolkenstein P; Roujeau JC
    Br J Dermatol; 2015 Jul; 173(1):50-8. PubMed ID: 25630796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
    Gill S; Sagar A; Shankar S; Nair V
    Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new type of minocycline-induced cutaneous hyperpigmentation.
    Mouton RW; Jordaan HF; Schneider JW
    Clin Exp Dermatol; 2004 Jan; 29(1):8-14. PubMed ID: 14723711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A severe case of minocycline-induced DRESS resulting in liver transplantation and autoimmune sequelae.
    Lan J; Lahoti A; Lew DB
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):367-8. PubMed ID: 26782675
    [No Abstract]   [Full Text] [Related]  

  • 18. Minocycline-induced skin pigmentation: an update.
    Geria AN; Tajirian AL; Kihiczak G; Schwartz RA
    Acta Dermatovenerol Croat; 2009; 17(2):123-6. PubMed ID: 19595269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris.
    Schrodt BJ; Kulp-Shorten CL; Callen JP
    South Med J; 1999 May; 92(5):502-4. PubMed ID: 10342897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute eosinophilic lung after a course of minocycline].
    Dussopt C; Mornex JF; Cordier JF; Brune J
    Rev Mal Respir; 1994; 11(1):67-70. PubMed ID: 8128099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.